We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+4.31%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$16.4B
AUM Growth
+$49.9M
(+0.3%)
Cap. Flow
-$355M
Cap. Flow
% of AUM
-2.16%
Top 10 Holdings %
Top 10 Hldgs %
43.8%
Holding
1,532
New
77
Increased
144
Reduced
521
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coty
COTY
|
+$139M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$38M |
| 3 |
GCP
GCP Applied Technologies Inc.
GCP
|
+$34.7M |
| 4 |
Sonida Senior Living
SNDA
|
+$25.5M |
| 5 |
Theravance Biopharma
TBPH
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$68M |
| 2 |
ConocoPhillips
COP
|
+$44.3M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$35.7M |
| 4 |
Zimmer Biomet
ZBH
|
+$33.7M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$26.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 37.47% |
| 2 | Healthcare | 12.64% |
| 3 | Industrials | 9.32% |
| 4 | Technology | 8.7% |
| 5 | Consumer Staples | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Ingredion
INGR
$6.32B
| $56.7M | 0.34% |
453,764
-4,748
| -1% | -$600K |
|
|
COL
52
DELISTED
Rockwell Collins
COL
| $55.4M | 0.34% |
597,519
-63,700
| -10% | -$5.61M |
|
53
Citigroup
C
$221B
| $54.8M | 0.33% |
922,159
-102,096
| -10% | -$5.51M |
|
54
Vornado Realty Trust
VNO
$7.34B
| $54.4M | 0.33% |
644,988
-3,367
| -0.5% | -$265K |
|
55
Liberty Global Class C
LBTYK
$3.37B
| $54.3M | 0.33% |
1,827,154
-57,605
| -3% | -$1.77M |
|
56
TriMas Corp
TRS
$1.44B
| $53.5M | 0.33% |
2,278,236
-96,455
| -4% | -$1.97M |
|
57
Brookfield Infrastructure Partners
BIP
$18.9B
| $53.2M | 0.32% |
2,670,506
+36,496
| +1% | +$719K |
|
|
58
Teva Pharmaceuticals
TEVA
$36.3B
| $52.6M | 0.32% |
1,451,632
+952,074
| +191% | +$38M |
|
59
Altria Group
MO
$120B
| $52.5M | 0.32% |
776,020
+177,647
| +30% | +$11.4M |
|
60
Ameren
AEE
$31.3B
| $52.1M | 0.32% |
992,598
-30,255
| -3% | -$1.5M |
|
|
GCP
61
DELISTED
GCP Applied Technologies Inc.
GCP
| $52M | 0.32% |
1,945,530
+1,282,332
| +193% | +$34.7M |
|
62
AutoZone
AZO
$47.7B
| $51.7M | 0.31% |
65,446
-2,456
| -4% | -$1.89M |
|
63
Capital One
COF
$123B
| $51.4M | 0.31% |
589,387
-3,004
| -0.5% | -$242K |
|
|
DISCK
64
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $50.3M | 0.31% |
1,880,058
-314,648
| -14% | -$8.3M |
|
65
PPG Industries
PPG
$25.4B
| $49.9M | 0.3% |
526,863
+160,778
| +44% | +$15.3M |
|
66
UnitedHealth
UNH
$385B
| $48.3M | 0.29% |
301,508
-16,883
| -5% | -$2.52M |
|
67
U-Haul Holding Co
UHAL
$14.1B
| $48.1M | 0.29% |
1,301,250
+70,640
| +6% | +$2.42M |
|
68
Texas Pacific Land
TPL
$29.4B
| $47.6M | 0.29% |
1,443,654
| – | – |
|
69
Procter & Gamble
PG
$342B
| $47.6M | 0.29% |
566,068
-92,513
| -14% | -$7.89M |
|
70
Kraft Heinz
KHC
$30.1B
| $46.9M | 0.29% |
537,625
-21,041
| -4% | -$1.8M |
|
71
Walt Disney
DIS
$161B
| $46.5M | 0.28% |
446,167
-18,425
| -4% | -$1.8M |
|
72
EOG Resources
EOG
$77.5B
| $45.6M | 0.28% |
451,006
-15,831
| -3% | -$1.54M |
|
73
ExxonMobil
XOM
$650B
| $43.8M | 0.27% |
485,152
-10,710
| -2% | -$936K |
|
|
TAST
74
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $43.4M | 0.26% |
2,847,572
-131,550
| -4% | -$1.73M |
|
|
GRA
75
DELISTED
W.R. Grace & Co.
GRA
| $43.3M | 0.26% |
640,747
-36,435
| -5% | -$2.49M |
|
Similar funds
SAM
First Manhattan's Q4 2016 Portfolio in Review
As of Q4 2016, First Manhattan held 1,532 positions worth $16.4B, up 0.3% from $16.4B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
First Manhattan's Q4 2016 filing shows 77 new, 144 increased, 521 reduced and 96 closed positions. Its largest new stake was Coty: 6,723,666 shares worth $123M. The largest sale was Allergan plc, an estimated $68M.
By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q4 2016 buy was Coty: 6,723,666 shares worth $123M.
- First Manhattan added most to Teva Pharmaceuticals in Q4 2016, an estimated $38M increase.
- First Manhattan's biggest Q4 2016 reduction was Allergan plc, cutting an estimated $68M.
- First Manhattan fully exited Starz - Series A in Q4 2016, selling an estimated $2.9M.
- First Manhattan's ten largest holdings make up 44% of its $16.4B portfolio in Q4 2016.
- First Manhattan opened 77 new positions and closed 96 in Q4 2016.
- First Manhattan's portfolio value rose 0.3% quarter-over-quarter to $16.4B.
Based on First Manhattan's 13F filing for Q4 2016, filed 25 Jan 2017.